NCT00709228View on ClinicalTrials.gov

Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793)

CompletedOBSERVATIONAL
Enrollment

496

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Hepatitis C
Interventions
DRUG

PegIntron

1.5 ug/kg/week

DRUG

Rebetol

800-1200 mg/day

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00709228 - Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793) | Biotech Hunter | Biotech Hunter